Complete Remission of Relapsed Hodgkin’s Lymphoma following Brentuximab Vedotin and Gemcitabine Combination Therapy with Severe Hypotension as Possible Treatment-Related Adverse Event: A Case Report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Complete Remission of Relapsed Hodgkin’s Lymphoma following Brentuximab Vedotin and Gemcitabine Combination Therapy with Severe Hypotension as Possible Treatment-Related Adverse Event: A Case Report ; volume:13 ; number:1 ; year:2020 ; pages:341-346
Case reports in oncology ; 13, Heft 1 (2020), 341-346
- Creator
-
Purwanto, Ibnu
Utomo, Bambang P.
Ghozali, Ahmad
- DOI
-
10.1159/000505830
- URN
-
urn:nbn:de:101:1-2020051400583771534886
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Purwanto, Ibnu
- Utomo, Bambang P.
- Ghozali, Ahmad
Other Objects (12)
Brentuximab Vedotin als Erstlinientherapie : Hodgkin-Lymphom
Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis
Brentuximab Vedotin beim Hodgkin Lymphom und systemischen ALCL : CD30-Positive Lymphone
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab Vedotin
Brentuximab vedotin resistance in classic Hodgkin's lymphoma and its therapeutic strategies: a review
Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
Cutaneous Hodgkin’s lymphoma
Sequentielle Hodgkin- und Non-Hodgkin-Lymphome
Lymphozytenmigration bei Non-Hodgkin- und Hodgkin-Lymphomen
Brentuximab Vedotin (CD30+ Hodgkin-Lymphom, Erstlinie) : Bewertung gemäß § 35a Abs. 1 Satz 11 SGB V
Brentuximab Vedotin als Erstlinientherapie : Hodgkin-Lymphom
Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis
Brentuximab Vedotin beim Hodgkin Lymphom und systemischen ALCL : CD30-Positive Lymphone
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab Vedotin
Brentuximab vedotin resistance in classic Hodgkin's lymphoma and its therapeutic strategies: a review
Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
Cutaneous Hodgkin’s lymphoma
Sequentielle Hodgkin- und Non-Hodgkin-Lymphome
Lymphozytenmigration bei Non-Hodgkin- und Hodgkin-Lymphomen
Brentuximab Vedotin (CD30+ Hodgkin-Lymphom, Erstlinie) : Bewertung gemäß § 35a Abs. 1 Satz 11 SGB V
Brentuximab Vedotin als Erstlinientherapie : Hodgkin-Lymphom
Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis
Brentuximab Vedotin beim Hodgkin Lymphom und systemischen ALCL : CD30-Positive Lymphone
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab Vedotin
Brentuximab vedotin resistance in classic Hodgkin's lymphoma and its therapeutic strategies: a review
Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
Cutaneous Hodgkin’s lymphoma
Sequentielle Hodgkin- und Non-Hodgkin-Lymphome
Lymphozytenmigration bei Non-Hodgkin- und Hodgkin-Lymphomen